These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39077485)

  • 21. Pharmacological management of heart failure in adults with congenital heart disease.
    Karnkowska B; Harmouch W; Newman P; Malik H; Khwaja B; Lewis A; Faluk M; Chatila K
    Heart Fail Rev; 2024 Aug; ():. PubMed ID: 39134780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death?
    deFilippi CR; Christenson RH; Kop WJ; Gottdiener JS; Zhan M; Seliger SL
    J Am Coll Cardiol; 2011 Sep; 58(14):1497-506. PubMed ID: 21939835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.
    Klemen P; Golub M; Grmec S
    Croat Med J; 2009 Apr; 50(2):133-42. PubMed ID: 19399946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasma concentration of growth-differentiation factor-15 in children with congenital heart disease: relation ship to heart function and diagnostic value in heart failure].
    Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Feb; 15(2):95-8. PubMed ID: 23428120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
    Bai J; Han L; Liu H
    Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.
    Guazzi M; Boracchi P; Labate V; Arena R; Reina G
    J Card Fail; 2012 Apr; 18(4):313-20. PubMed ID: 22464773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuning and external validation of an adult congenital heart disease risk prediction model.
    Geenen LW; Opotowsky AR; Lachtrupp C; Baggen VJM; Brainard S; Landzberg MJ; van Klaveren D; Lingsma HF; Boersma E; Roos-Hesselink JW
    Eur Heart J Qual Care Clin Outcomes; 2022 Jan; 8(1):70-78. PubMed ID: 33313813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.
    McKie PM; Cataliotti A; Lahr BD; Martin FL; Redfield MM; Bailey KR; Rodeheffer RJ; Burnett JC
    J Am Coll Cardiol; 2010 May; 55(19):2140-7. PubMed ID: 20447539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes and healthcare resource utilization in adult congenital heart disease patients with heart failure.
    Tsang W; Silversides CK; Rashid M; Roche SL; Alonso-Gonzalez R; Austin PC; Lee DS
    ESC Heart Fail; 2021 Oct; 8(5):4139-4151. PubMed ID: 34402222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
    Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
    Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.
    Kalogeropoulos AP; Georgiopoulou VV; deFilippi CR; Gottdiener JS; Butler J;
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):131-40. PubMed ID: 22340818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiopoietin-2 in adults with congenital heart disease and heart failure.
    Lukasz A; Beutel G; Kümpers P; Denecke A; Westhoff-Bleck M; Schieffer B; Bauersachs J; Kielstein JT; Tutarel O
    PLoS One; 2013; 8(6):e66861. PubMed ID: 23826161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
    Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
    Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amniotic Fluid Natriuretic Peptide Levels in Fetuses With Congenital Heart Defects or Arrhythmias.
    Miyoshi T; Hosoda H; Umekawa T; Asada T; Fujiwara A; Kurosaki KI; Shiraishi I; Nakai M; Nishimura K; Miyazato M; Kangawa K; Ikeda T; Yoshimatsu J; Minamino N
    Circ J; 2018 Sep; 82(10):2619-2626. PubMed ID: 29998930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
    ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease.
    Lowenthal A; Camacho BV; Lowenthal S; Natal-Hernandez L; Liszewski W; Hills NK; Fineman JR; Bernstein HS
    Am J Cardiol; 2012 Mar; 109(6):866-72. PubMed ID: 22196786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term Prognostic Value of Heart Failure Diagnosis in a Contemporary Cohort of Patients With Adult Congenital Heart Disease.
    Maessen L; De Meester P; Troost E; Gewillig M; Rega F; Moons P; Budts W; Van De Bruaene A
    Can J Cardiol; 2023 Mar; 39(3):292-301. PubMed ID: 36581247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department.
    Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL;
    Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.